Results 81 to 90 of about 119,637 (222)

Somatostatin receptor scintigraphy: Its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion [PDF]

, 1994
purpose: To assess the feasibility of somatostatin receptor scintigraphy for patients with Cushing's syndrome caused by tumors secreting ectopic corticotropin or corticotropin-releasing hormone (CRH).
Bruining, H.A. (Hajo), Herder, W.W. (Wouter) de, Hofland, L.J. (Leo), Kreniming, E.P. (Eric), Kwekkeboom, D.J. (Dirk Jan), Lamberts, S.W.J. (Steven), Malchoff, C.D. (Carl), Nobels, F.R.E. (Frank), Oei, H.Y. (H.), Pols, H.A.P. (Huib), Reubi, J.-C. (Jean-Claude)   +10 more
core   +1 more source

Novel therapeutic strategy targeting STMN1 using chlorambucil‐conjugated pyrrole–imidazole polyamide in small cell lung cancer

International Journal of Cancer, Volume 158, Issue 5, Page 1336-1347, 1 March 2026.
What's New? Small cell lung cancer (SCLC) is aggressive and difficult to treat but exhibits high levels of stathmin 1 (STMN1), a candidate therapeutic target. In this study, the authors synthesized a chlorambucil (Chb)‐conjugated pyrrole–imidazole polyamide (PIP) compound targeting the STMN1 promoter and DNA sequences and evaluated its efficacy in ...
Ryohei Yoshikawa, Takayoshi Watanabe, Yoichi Ohtaki, Toshikazu Bando, Hiroshi Sugiyama, Takuya Araki, Hideaki Yashima, Bilguun Erkhem‐Ochir, Haruka Okami, Gendensuren Dorjkhorloo, Ikuma Shioi, Toshiteru Nagashima, Natsuko Kawatani, Tomohiro Yazawa, Eiji Narusawa, Takayuki Kosaka, Osamu Kawashima, Mitsuhiro Kamiyoshihara, John D. Minna, Luc Girard, Ken Shirabe, Hiroki Nagase, Kimihiro Shimizu, Takehiko Yokobori   +23 more
wiley   +1 more source

A Rare Primary Neuroendocrine Tumor (Typical Carcinoid) of the Sublingual Gland

Case Reports in Dentistry, 2016
A typical carcinoid is extremely rare in the oral cavity. We here present a case of a typical carcinoid arising in the sublingual gland of a 62-year-old woman.
Kenji Yamagata, Kousuke Ohki, Fumihiko Uchida, Naomi Kanno, Shogo Hasegawa, Toru Yanagawa, Hiroki Bukawa   +6 more
doaj   +1 more source

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. [PDF]

, 2016
BackgroundEverolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, is used to treat solid tumors and tuberous sclerosis complex (TSC). Stomatitis, an inflammation of the mucous membranes of the mouth, is a common adverse event associated with ...
Anak, O, Franz, D, Gallo, J, Hortobagyi, GN, Motzer, R, Pavel, M, Ravaud, A, Ringeisen, F, Rouyrre, N, Rugo, HS, Yao, J   +10 more
core  

Clinical Versus Pathologic Staging in Early‐Stage Non‐Small Cell Lung Cancer Assessed by an Established Lung Cancer Multidisciplinary Meeting

Thoracic Cancer, Volume 17, Issue 6, March 2026.
Clinical and pathological staging concordance in early‐stage NSCLC occurred in 73% of cases. Clinical under‐staging occurred in 18.9% of cases. Under‐staging was associated with treatment delays and tumor histopathology and increased the risk of disease recurrence and mortality.
James Nolan, Theron Sather, Craig Hukins, Michelle Murphy   +3 more
wiley   +1 more source

Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil [PDF]

, 2013
Background: Paraneoplastic cerebellar degeneration (PCD) is a classical tumor-associated, immune-mediated disease typically associated with gynecological malignancies, small-cell lung-cancer or lymphoma.
Hartmann, Sylvia, Henke, Christian, Middendorp, Marcus, Rieger, Johannes, Steinmetz, Helmuth, Ziemann, Ulf   +5 more
core   +1 more source

What Is Your Diagnosis? Splenic Mass in an African Pygmy Hedgehog

Veterinary Clinical Pathology, EarlyView.
Gabriela Hartmann, Milena Carolina Paz, Paola Sônego, Ana Carolina Contri Natal, Lívia Surita, Marcele Bettim Bandinelli, Luciana Sonne   +6 more
wiley   +1 more source

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues [PDF]

, 2015
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release (pasireotide LAR) with octreotide long-acting repeatable (octreotide LAR) in managing carcinoid symptoms refractory to first-generation somatostatin analogues ...
Eriksson, B., Fogelman, D.R., Gadbaw, B., Jarzab, B., Li, J., Mahamat, A., Mansoor, W., Morse, M.A., Newell-Price, J., Oeberg, K., Pasieka, J.L., Poon, D., Ramage, J., Swahn, F., Tomassetti, P., Toumpanakis, C., Walter, T., Weber, M.M., Wolin, E.M.   +18 more
core   +3 more sources

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin

Clinical Ophthalmology, 2013
Setsuko Kawakami, Yoshihiro Wakabayashi, Hiroshi Goto Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan Abstract: We report a case of metastatic choroidal carcinoid tumor with favorable outcome after photodynamic therapy.
Kawakami S, Wakabayashi Y, Goto H
doaj  

Atelectasis in pediatrics: a case of carcinoid tumor

Rare Tumors, 2017
Carcinoid pulmonary tumors occur in the fourth to sixth decades of life. Usually, typical carcinoid arise a decade earlier when compared to atypical carcinoid (45 years and 55 years, respectively).
Cláudia Guerreiro, Paula Ornelas, Luísa Pereira, Nuno Abecasis, Maria Teresa Almodovar   +4 more
doaj   +1 more source